News

Read the Patient Information Leaflet and Instructions for Use if available from your pharmacist before you start using immune globulin and each time you get a refill. If you have any questions ...
Symptoms at the time of diagnosis included frequent ophthalmitis and chronic congestion. The patient estimated her daily morning sputum production as between a tablespoon and a cup. On examination ...
Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...
HyQvia is the only up to once monthly subcutaneous immunoglobulin infusion to treat CIDP in Canada and can be administered by a healthcare professional or self-administered with training ...
Before using this medication, tell your doctor or pharmacist your medical history, especially of: blood clotting problems, immunoglobulin A deficiency, kidney disease. Before having surgery ...
HyQvia is the only up to once monthly (every 2, 3 or 4 weeks) immunoglobulin subcutaneous infusion to treat CIDP in Canada TORONTO, March 27, 2025 /CNW/ - Takeda Canada Inc. (Takeda) is pleased to ...
Biotechnology pioneer Halozyme has developed ENHANZE, a drug delivery technology that can enable and optimize the subcutaneous ... injections required for SC immunoglobulin formulated without ...
Canada announced that Health Canada has expanded the marketing authorization for HyQvia for chronic inflammatory demyelinating ...